JPRN-UMIN000019225已完成未知
A phase II study combining gemcitabine and carboplatin in patients with platinum-resistant ovarian cancer - A phase II study combining gemcitabine and carboplatin in patients with platinum-resistant ovarian cancer
Osaka medical coledge0 个研究点目标入组 30 人开始时间: 2015年10月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •The organization type including sarcoma
研究者
相似试验
已完成
不适用
A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urotheliumCancerISRCTN88259320School of Medicine, Zhejiang University (China)39
未知
不适用
Phase II study of carboplatin-gemcitabine combination chemotherapy in elderly patients with advanced non–small cell lung cancerJPRN-C000000112Kumamoto University School of Medicine55
已完成
不适用
Phase 2 study of the combination of gemcitabine and nedaplation for treatment of previously untreated advanced squamous cell lung cancerung squamous cell carcinomaJPRN-UMIN000004833First Department of Surgery, Hamamatsu University School of Medicine25
未知
1 期
Phase 1/2 study of the combination of gemcitabine and nedaplation for treatment of previously untreated advanced squamous cell lung cancerPreaviously untreated advanced advanced squamous cell lung cancerJPRN-C000000439Department of Respiratory Medicine of Kyoto University Hospital32
已完成
2 期
A combination phase II study of gemcitabine with carboplatin for previously untreated elderly non-small cell lung cancer.on-small cell lung cancerJPRN-C000000135Institute of Biomedical Research and Innovation40